New study tests minimally invasive heart valve repair to cut hospital stays
NCT ID NCT07197021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a minimally invasive heart valve repair procedure (TEER) plus standard medication can reduce hospital readmissions over two years in people with moderate mitral regurgitation that worsens with exertion. About 300 participants will be randomly assigned to receive either the procedure plus medication or medication alone. The goal is to see if fixing the leaky valve helps the heart work better and keeps patients out of the hospital.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION FUNCTIONAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a valve fix unlock better heart failure drugs?
- Heart valve repair may unlock better drug dosing for heart failure
- Exercise-Triggered heart valve leak targeted in new trial
- New heart device aims to fix leaky valves without open surgery
- New heart valve clip aims to ease breathing and cut hospital visits
- Tiny ring could fix leaky heart valve without open surgery